CYT-1010

• UNSPSC Description:

  CYT-1010 is a mu-opioid receptor agonist extracted from patent WO2013173730A2, with EC50s of 13.1 nM and 0.0053 nM on beta-arrestin recruitment and inhibition of cAMP production, respectively[1].

• Target Antigen:

  Opioid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cyt-1010.html

• Purity:

  99.74

• Solubility:

  DMSO : 125 mg/mL (ultrasonic)

• Smiles:

  OC1=CC=C(C=C1)C[C@@H](C(N[C@H](CCCCNC2=O)C(N[C@@H](CC3=CNC4=C3C=CC=C4)C(N[C@H]2CC5=CC=CC=C5)=O)=O)=O)N

• Molecular Weight:

  624.73

• References & Citations:

  [1]Theodore E. Maione, Novel therapeutic uses of mu-opiate receptor peptides. WO2013173730A2.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Phase 1

• CAS Number:

  213769-33-6